Antibody to Infliximab ELISA
Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Infliximab (Remicade®, Remsima®) in serum and plasma.
The solid phase (MTP) is coated by the drug Infliximab. Due to the assay design this test only measures the free antibodies which are not bound to Infliximab. Results are expressed in AU (arbitrary units).
Legal Status: CE-Mark
Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Remicade® is a trademark of Janssen Biotech, Inc./Merck & Co.
Remsima® is a trademark of CellTrion Inc.
The Kit at a glance:
|Required Volume (µL)||10|
|Incubation Time (min)||135|
|Sample||Serum or Plasma|
|Package Size||96 Tests|
|Results in||Arbitrary Units (AU/mL)|
|Shelf Life (years)||2|